Hypothyroidism is a common endocrine problem affecting mostly women. If untreated, it leads to impaired quality of life and function. The standard therapy for hypothyroidism, as recommended by the American Thyroid Association® (ATA), is synthetic levothyroxine, a safe and effective therapy. The US Food and Drug Administration (FDA) regulates levothyroxine medications to ensure bioavailability, dose equivalence, potency, and purity.
September 11, 2025 – The American Thyroid Association® is delighted to recognize W. Edward Visser,…
The American Thyroid Association has released new guidelines for the management of adult patients with differentiated thyroid cancer (DTC), the most prevalent cancer of the thyroid. The guidelines are published in the peer-reviewed journal Thyroid®, the official journal of the American Thyroid Association® (ATA®)
2025 AMERICAN THYROID ASSOCIATION GRANT RECIPIENTS Arturo Mendoza, PhD Boston University, United States Thyroid Hormone…
Each year, the American Thyroid Association® (ATA®) honors clinicians, academicians and early career researchers who have made outstanding contributions in thyroidology. These awards honor both professional achievements and contributions to ATA.
As 2024 comes to a close, we would like to take the opportunity to share…
FOR IMMEDIATE RELEASE December 6, 2024 Contact: Hayley Gray-Hoehn, hayley.gray-hoehn@mail.house.gov Washington, D.C. – Wednesday, U.S….
Each year, the American Thyroid Association® (ATA®) honors clinicians, academicians and early career researchers who…
The ATA announces with pleasure that Jacqueline Jonklaas, MD, PhD, a Professor of Endocrinology at…
Coverage from the American Thyroid Association® (ATA) 2024 Meeting October 30-November 3, 2024 Sheraton Grand…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.© 2025 American Thyroid Association.
